Tag: Keith J Kendall

Aquestive's Subingual Epinephrine

Aquestive Charts Ambitious Path Forward for Sublingual Emergency Epinephrine

Company updates the public on status of their candidate drug administered under the tongue.
AQST-108 Phase 1

Emergency Epinephrine Film Begins Phase 1 Clinical Trials

First healthy volunteer dosed in a Phase 1 study of AQST-108 for the treatment of allergic reactions including anaphylaxis.
Aquestive AQST-108 Epinephrine Film

Aquestive’s Sublingual Epinephrine Film Receives FDA Fast Track Designation for Treatment...

First planned PK clinical trial expected to begin during the third quarter of 2020.
Aquestive AQST-108 Epinephrine Film

Aquestive Files IND to Begin Clinical Trials of Sublingual Epinephrine

Epinephrine you slip under your tongue takes another step forward as the company submits their IND application.